• In late June 2026, Astera Labs, Inc. joined the Nasdaq-100 Index while being removed from the Russell 2500 and Russell 2500 Growth benchmarks, reshaping how it is represented across major equity indices.
• This reshuffling underscores Astera Labs’ transition toward a larger-cap AI infrastructure role, as demand for its Scorpio connectivity solutions reshapes its investor base.
• We’ll now examine how Nasdaq-100 inclusion, alongside strengthening Scorpio demand, may influence Astera Labs’ existing investment narrative and risk balance.

Capitalize on the AI infrastructure supercycle with our selection of the 52 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Astera Labs Investment Narrative Recap

To own Astera Labs today, you have to believe AI data centers will keep prioritizing open, high performance connectivity and that Scorpio remains central to those buildouts. Nasdaq 100 inclusion mainly affects who owns the stock and its liquidity, not the core business. The key near term catalyst is still execution on the Scorpio P and X production ramp, while the biggest risk remains heavy dependence on hyperscaler AI capex and a concentrated customer base.

Among the recent announcements, the May launch of the Scorpio X Series 320 lane smart fabric switch stands out as most relevant. It reinforces Astera Labs’ positioning in large scale AI clusters right as index inclusion draws more benchmarked capital to the name. If Scorpio X samples convert into broad deployments during the planned H2 2026 ramp, it could meaningfully reinforce the existing growth narrative around AI infrastructure connectivity.

Yet alongside the excitement, investors should be aware that customer concentration and shifting AI capex priorities could still...

Astera Labs' narrative projects $2.6 billion revenue and $668.5 million earnings by 2029. This requires 37.8% yearly revenue growth and about a $401 million earnings increase from $267.6 million today.

Uncover how Astera Labs' forecasts yield a $244.97 fair value, a 43% downside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were already modeling Astera Labs to reach about US$3.2 billion of revenue and roughly US$921.5 million of earnings by 2029 before this index news, which is far more upbeat than consensus and assumes hyperscaler demand and open standards adoption stay very strong; as you weigh that against the risk that spending or standards could shift, it is worth exploring how your own expectations line up with these very different views.

Explore 12 other fair value estimates on Astera Labs - why the stock might be worth as much as $272.47!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Astera Labs research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Astera Labs research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Astera Labs' overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• We've uncovered the 8 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Uncover the next big thing with 21 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.